AMD has described its RDNA 4 graphics card launch as "unprecedented" in a new interview, promising that restocks of the two ...
REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates
Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with Nippon Shinyaku aims to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback